NCT05229822View on ClinicalTrials.gov

Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Intestinal ObstructionColorectal CancerPost-Op ComplicationSystemic Inflammatory Response SyndromeColon Tumor
Interventions
DIAGNOSTIC_TEST

LBP

Determine any presence of LBP in blood serum by ELISA method 1 hour before surgery, 24 and 72 hours after it.

DIAGNOSTIC_TEST

sCD14-ST

Determine any presence of sCD14-ST in blood serum by ELISA method 1 hour before surgery, 24 and 72 hours after it.

DIAGNOSTIC_TEST

16s rRNA

Determine any presence of 16s rRNA in mesenteric lymph nodes by PCR method.

Trial Locations (1)

100000

NJSC Karaganda Medical University, Karaganda

All Listed Sponsors
collaborator

Ministry of Education and Science, Republic of Kazakhstan

OTHER_GOV

lead

Karaganda Medical University

OTHER

NCT05229822 - Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | Biotech Hunter | Biotech Hunter